FDA Investigator Charles Yuanchia Kuo, PhD
Charles Yuanchia Kuo, PhD has conducted inspections on 6 sites in 1 countries as of 31 Oct 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
31 Oct 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Charles Yuanchia Kuo, PhD:
Aditi S Thakur,
Alan L Truong,
Alberto A Viciedo,
Alice C Silva,
Amy Devlin, PhD,
Andrew "Drew" Haack, PhD,
Andrew J Barrowcliff,
Andrew K Haack, PhD,
Anita Narula, PhD,
Arie C Menachem,
Ashutosh Rao, PhD,
Barbara Janine Breithaupt,
Bo Chi, PhD,
Bonita S Chester,
Brian M Janelsins, PhD,
Byungja E Marciante,
CDR Donald Ertel,
Chava Kimchi Sarfaty, PhD,
Christopher Downey, PhD,
Christopher R Czajka,
Colleen F Hoyt,
Cristina Ausin Moreno, PhD,
Dawn L Wydner,
Deborah M Trout,
Devaughn Edwards,
Diane L Raccasi,
Dolores Harper,
Dr. Zhihao Qiu (Peter), PhD,
Eboni S Funderburk,
Edmund F Mrak, Jr,
Edwin Jao,
Ellen P Madigan,
Emilie E Kahn,
Esther C Broner, PhD,
Guerlain Ulysse,
Haley H Seymour,
Hyung Yul Lee,
Jacek Cieslak, PhD,
Jacob G Lutz,
James A Lane,
Janet L Bowen,
Jason F Chancey,
Jee Chung, PhD,
Jeffrey D Meng,
Jie He,
Joan Johnson,
John P Mistler,
Jon P Antoniou,
Jose Ohernandez Guzman,
Joslyn K Brunelle, PhD,
Justin A Boyd,
Kathleen M Jordan,
Kathryn E King,
Ko U Min,
LCDR Debra Emerson,
LCDR Sean Byrd,
Leiyun Boone, PhD,
Leopold Kong, PhD,
Leslie Arivera Rosado, PhD,
Lisa K Capron,
Logan T Williams,
Maria Cruz Fisher,
Marlene G Swider,
Mary Jeanet Mcgarry,
Mary Kaulee,
Megan A Haggerty,
Meisha R Sampson,
Meisha Waters,
Michael P Anthony,
Michael R Klapal,
Michael S Araneta,
Michael Shanks, MS,
Michele L Forster, PhD,
Michele Perry Williams,
Michelle M Noe Varga,
Mihaly S Ligmond,
Mikhail V Ovanesov, PhD,
Muna Algharibeh,
Nailing Zhang,
Nataniel Phillips Sylvain, PhD,
Nicholas L Paulin,
Patricia F Hughes, PhD,
Paul L Bellamy,
Paula A Trost,
Penny H Mccarver,
Prabhu P Raju,
Qiao Y Bobo,
Rabia Ballica, PhD,
Rachael O Oyewole,
Rafeeq A Habeeb,
Ramon E Martinez,
Richard Ledwidge (nmi), PhD,
Riley C Myers, PhD,
Robert Barbosa,
Robert J Martin,
Robert M Barbosa,
Russell J Glapion,
S Lori Brown, PhD MPH,
Saleem A Akhtar,
Samuel Mindaye,
Sandra A Boyd,
Sargum C Sood,
Scott C Lute,
Scott R Nichols, PhD,
Seneca D Toms,
Simon Williams, PhD,
Sneha S Patel,
Sonya M Edmonds,
Steven Fong, MS, PhD,
Tamil Arasu, PhD,
Teegan Dellibovi Ragheb, PhD,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Timothy J Schmidt,
V Teres Speer,
Vaishali J Patel,
Vanessa Y Gelsey, PhD,
Vanessa Y Jacobs,
Veronica Fuentes, MS,
Wayne E Seifert,
Wendy G Tan, PhD,
Xiaoxiao Pan, PhD,
Xuhong Li,
Yan Wang,
Yanming An, PhD,
Yideng Liang,
Yuan Chia Kuo,
Yun Wu, PhD,
Yvesna C Blaise,
Zhenzhen Liu, PhD,
Zhong Li, PhD
Charles Yuanchia Kuo, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| March, 2023 | FDA 483 | Rentschler Biopharma Inc. - Form 483, 2023-03-22 |
| March, 2022 | FDA 483 | Shire Human Genetic Therapies, Inc. - Form 483, 2022-03-23 |
| November, 2023 | FDA 483 | Catalent Indiana, LLC - Form 483, 2023-11-15 |
| February, 2023 | FDA 483 | AGC Biologics, Inc. - Form 483, 2023-02-10 |
| July, 2023 | FDA 483 | ImClone Systems LLC - Form 483, 2023-07-27 |
| February, 2023 | EIR | AGC Biologics, Inc. - EIR, 2023-05-24 |
| February, 2023 | FDA 483 | FUJIFILM Diosynth Biotechnologies U.S.A., Inc - Form 483, 2023-02-10 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more